Vicarious Surgical (RBOTW) Notes Payables (2020 - 2025)
Vicarious Surgical (RBOTW) reported Notes Payables of $525000.0 for Q4 2025, up 323.56% on a QoQ basis from $123950.0 in Q2 2020.
Vicarious Surgical (RBOTW) has 2 years of Notes Payables data on file, last reported at $525000.0 in Q4 2025.
- Quarterly Notes Payables changed N/A year-over-year to $525000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $525000.0 (changed N/A YoY) and the FY2025 annual result came in at $525000.0, changed N/A from the prior year.
- Notes Payables rose to $525000.0 in Q4 2025 per RBOTW's latest filing, from $123950.0 in the prior quarter.
- Across five years, Notes Payables topped out at $525000.0 in Q4 2025 and bottomed at $525000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vicarious Surgical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 525,000.00 |
| Jun 30, 2020 | 123,950.00 |